2025-08960Notice

FDA Seeks Input on a Rare Deficiency and Chemotherapy

Published Date: 5/20/2025

Notice

Summary

The FDA is opening a public comment period to learn more about a condition called DPD deficiency, which can affect how people react to certain chemotherapy drugs like fluorouracil and capecitabine. This effort aims to gather info to keep patients safe and improve treatment. Anyone interested has until June 20, 2025, to share their thoughts—no costs or immediate changes yet, just gathering input!

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Effective Date
5/20/2025
6/20/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register